Physician profile
Doron Ber
NPI 1316924749
$14,386.46
in general payments reported to CMS, 2019-2025
21 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,490 · 2020: $3,347 · 2021: $1,124 · 2022: $98.91 · 2023: $29.16 · 2024: $125 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $7,441.02 | 2019-2022 | |
| Optinose US, INC. | $3,224.18 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $875.00 | 2021 | |
| Csl Behring | $589.94 | 2019-2025 | Haegarda, Andembry |
| Astrazeneca Pharmaceuticals LP | $381.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $368.42 | 2019-2024 | |
| Genzyme Corporation | $237.48 | 2019-2020 | |
| Pfizer INC. | $206.75 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.61 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $157.58 | 2019 | |
| Genentech USA, INC. | $121.82 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $114.22 | 2025 | Neffy |
| Octapharma USA, INC. | $110.82 | 2019 | |
| Shire North American Group INC | $95.71 | 2019 | |
| Alk-Abello, INC | $79.30 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $58.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.96 | 2019 | |
| Aimmune Therapeutics, INC. | $27.24 | 2020 | |
| Greer Laboratories, INC. | $24.54 | 2019 | |
| Philips North America LLC | $16.93 | 2019 | |
| Circassia INC. | $16.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doron Ber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.